Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
vTv Therapeutics Inc. (VTVT) Debt to Equity Ratio data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$1.02M |
|
$-18.46M |
|
-- |
|
$1.02M |
|
$25.20M |
|
$-24.18M |
|
$1.57M |
|
$-22.61M |
|
$-22.61M |
|
$-22.70M |
|
$-22.70M |
|
$-22.70M |
|
$-22.70M |
|
$-24.18M |
|
$-24.09M |
|
5.77M |
|
5.77M |
|
$-3.20 |
|
$-3.20 |
|
| Balance Sheet Financials | |
$38.11M |
|
$0.03M |
|
$0.15M |
|
$38.27M |
|
$5.20M |
|
-- |
|
$18.77M |
|
$23.96M |
|
$14.30M |
|
$14.30M |
|
$14.30M |
|
3.19M |
|
| Cash Flow Statement Financials | |
$-25.31M |
|
-- |
|
$52.61M |
|
$9.45M |
|
$36.75M |
|
$27.30M |
|
$2.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.34 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
-- |
100.00% |
|
-2377.58% |
|
-2377.58% |
|
-2368.83% |
|
-2222.71% |
|
-1815.34% |
|
$-25.31M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
16.40 |
|
22.25 |
|
-158.76% |
|
-158.77% |
|
-59.33% |
|
-158.77% |
|
$4.48 |
|
$-4.39 |
|
$-4.39 |
|